The pharmaceutical industry has great potential for development

The pharmaceutical industry has great potential for development
Pharmaceutical intermediates are chemical raw materials or chemical products that need to be used in synthesis process of medicines. These chemical products, as long as the technical indicators meet certain level requirements, can be used to participate in the synthesis and production of medicine, and can be produced in ordinary chemical plants without obtaining a drug manufacture license. As one of the three pillars of the pharmaceutical industry, the market access threshold for finished pharmaceutical products (FPP) and API need to accept GMP certification while the manufacturers of pharmaceutical intermediates do not, because intermediate products belong to the bottom and the most basic products in the pharmaceutical production chain and can not be called finished pharmaceutical products, they do not need to go through GMP certification.
Pharmaceutical intermediates can be divided into several categories according to application areas: antibiotics, antipyretic and analgesic intermediates, anti-cancer intermediates and cardiovascular intermediates. There are many kinds of intermediates under each category, which are not listed here. As a big producer of pharmaceutical intermediates, China has a huge production capacity of intermediates every year, and the overall supply exceeds demand, so China is a big exporter of pharmaceutical intermediates, and its export products are mainly concentrated in vitamin C, penicillin, citric acid, acetaminophen and salt esters and other bulk products. These products are characterized by huge production, many domestic manufacturers of intermediates in this area in China and low product prices.
Looking at the whole industry, there are several main characteristics of China’s pharmaceutical intermediates industry. Firstly, most of the manufacturers are private enterprises, the investment scale is not large and the individual production capacity is not large; secondly, the geographical distribution of Chinese pharmaceutical intermediates manufacturers is mainly concentrated in Jiangsu and Zhejiang in eastern China; thirdly as China pays more and more attention to environmental protection, Chinese pharmaceutical intermediates manufacturers are forced to continuously upgrade their industry due to the pressure of environmental production; fourthly, the industry is competitive and the profit margin is reduced forcing manufacturers to continuously develop new products or improve the process. The fourth is that the industry is competitive and the profit is decreasing, forcing manufacturers to develop new products or improve the process. Due to the low threshold of the industry more and more small and medium-sized manufacturers join the ranks of pharmaceutical intermediates, leading to increasingly fierce competition in the industry. Compared with Chinese API manufacturers, the profit margin of Chinese pharmaceutical intermediates manufacturers is low, and the production process of API and intermediates is very similar, so some companies not only produce intermediates but also start to produce API with their own advantages. 
Pharmaceutical intermediates, as an important industry in the field of chemical industry and pharmaceutical field, has become an industry that has attracted much attention in recent years. With the progress of science and technology, many new medicines are constantly developed and benefit human beings, these new medicines came from the production of new and high quality pharmaceutical intermediates, the development space and application prospect of pharmaceutical intermediates market is very broad, but intermediates manufacturers should establish long-term stable supply relationship with pharmaceutical companies to ensure the smooth sales of products and in the increasingly fierce competition in the market development and growth.